196 related articles for article (PubMed ID: 18988803)
1. Ras signaling influences permissiveness of malignant peripheral nerve sheath tumor cells to oncolytic herpes.
Farassati F; Pan W; Yamoutpour F; Henke S; Piedra M; Frahm S; Al-Tawil S; Mangrum WI; Parada LF; Rabkin SD; Martuza RL; Kurtz A
Am J Pathol; 2008 Dec; 173(6):1861-72. PubMed ID: 18988803
[TBL] [Abstract][Full Text] [Related]
2. Malignant peripheral nerve sheath tumors with high and low Ras-GTP are permissive for oncolytic herpes simplex virus mutants.
Mahller YY; Rangwala F; Ratner N; Cripe TP
Pediatr Blood Cancer; 2006 Jun; 46(7):745-54. PubMed ID: 16124003
[TBL] [Abstract][Full Text] [Related]
3. Transcription factors down-stream of Ras as molecular indicators for targeting malignancies with oncolytic herpes virus.
Esfandyari T; Tefferi A; Szmidt A; Alain T; Zwolak P; Lasho T; Lee PW; Farassati F
Mol Oncol; 2009 Dec; 3(5-6):464-8. PubMed ID: 19766068
[TBL] [Abstract][Full Text] [Related]
4. Oncolytic HSV and erlotinib inhibit tumor growth and angiogenesis in a novel malignant peripheral nerve sheath tumor xenograft model.
Mahller YY; Vaikunth SS; Currier MA; Miller SJ; Ripberger MC; Hsu YH; Mehrian-Shai R; Collins MH; Crombleholme TM; Ratner N; Cripe TP
Mol Ther; 2007 Feb; 15(2):279-86. PubMed ID: 17235305
[TBL] [Abstract][Full Text] [Related]
5. ErbB4 promotes malignant peripheral nerve sheath tumor pathogenesis via Ras-independent mechanisms.
Longo JF; Brosius SN; Black L; Worley SH; Wilson RC; Roth KA; Carroll SL
Cell Commun Signal; 2019 Jul; 17(1):74. PubMed ID: 31291965
[TBL] [Abstract][Full Text] [Related]
6. NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Park HJ; Lee SJ; Sohn YB; Jin HS; Han JH; Kim YB; Yim H; Jeong SY
Int J Oncol; 2013 Feb; 42(2):657-66. PubMed ID: 23292448
[TBL] [Abstract][Full Text] [Related]
7. Oncogenes in Ras signalling pathway dictate host-cell permissiveness to herpes simplex virus 1.
Farassati F; Yang AD; Lee PW
Nat Cell Biol; 2001 Aug; 3(8):745-50. PubMed ID: 11483960
[TBL] [Abstract][Full Text] [Related]
8. Overactivation of Ras signaling pathway in CD133+ MPNST cells.
Borrego-Diaz E; Terai K; Lialyte K; Wise AL; Esfandyari T; Behbod F; Mautner VF; Spyra M; Taylor S; Parada LF; Upadhyaya M; Farassati F
J Neurooncol; 2012 Jul; 108(3):423-34. PubMed ID: 22484909
[TBL] [Abstract][Full Text] [Related]
9. Ral overactivation in malignant peripheral nerve sheath tumors.
Bodempudi V; Yamoutpoor F; Pan W; Dudek AZ; Esfandyari T; Piedra M; Babovick-Vuksanovic D; Woo RA; Mautner VF; Kluwe L; Clapp DW; De Vries GH; Thomas SL; Kurtz A; Parada LF; Farassati F
Mol Cell Biol; 2009 Jul; 29(14):3964-74. PubMed ID: 19414599
[TBL] [Abstract][Full Text] [Related]
10. Classic Ras Proteins Promote Proliferation and Survival via Distinct Phosphoproteome Alterations in Neurofibromin-Null Malignant Peripheral Nerve Sheath Tumor Cells.
Brossier NM; Prechtl AM; Longo JF; Barnes S; Wilson LS; Byer SJ; Brosius SN; Carroll SL
J Neuropathol Exp Neurol; 2015 Jun; 74(6):568-86. PubMed ID: 25946318
[TBL] [Abstract][Full Text] [Related]
11. Assessment of oncolytic HSV efficacy following increased entry-receptor expression in malignant peripheral nerve sheath tumor cell lines.
Jackson JD; McMorris AM; Roth JC; Coleman JM; Whitley RJ; Gillespie GY; Carroll SL; Markert JM; Cassady KA
Gene Ther; 2014 Nov; 21(11):984-90. PubMed ID: 25119379
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic measles virus as a novel therapy for malignant peripheral nerve sheath tumors.
Deyle DR; Escobar DZ; Peng KW; Babovic-Vuksanovic D
Gene; 2015 Jul; 565(1):140-5. PubMed ID: 25843626
[TBL] [Abstract][Full Text] [Related]
13. Molecular engineering and validation of an oncolytic herpes simplex virus type 1 transcriptionally targeted to midkine-positive tumors.
Maldonado AR; Klanke C; Jegga AG; Aronow BJ; Mahller YY; Cripe TP; Crombleholme TM
J Gene Med; 2010 Jul; 12(7):613-23. PubMed ID: 20603890
[TBL] [Abstract][Full Text] [Related]
14. Galectin-1 inhibition induces cell apoptosis through dual suppression of CXCR4 and Ras pathways in human malignant peripheral nerve sheath tumors.
Shih TC; Fan Y; Kiss S; Li X; Deng XN; Liu R; Chen XJ; Carney R; Chen A; Ghosh PM; Lam KS
Neuro Oncol; 2019 Nov; 21(11):1389-1400. PubMed ID: 31127849
[TBL] [Abstract][Full Text] [Related]
15. Permissiveness of human cancer cells to oncolytic bovine herpesvirus 1 is mediated in part by KRAS activity.
Cuddington BP; Mossman KL
J Virol; 2014 Jun; 88(12):6885-95. PubMed ID: 24696490
[TBL] [Abstract][Full Text] [Related]
16. Combinatorial therapeutic targeting of BMP2 and MEK-ERK pathways in NF1-associated malignant peripheral nerve sheath tumors.
Ahsan S; Ge Y; Tainsky MA
Oncotarget; 2016 Aug; 7(35):57171-57185. PubMed ID: 27494873
[TBL] [Abstract][Full Text] [Related]
17. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
18. Utilizing ras signaling pathway to direct selective replication of herpes simplex virus-1.
Pan W; Bodempudi V; Esfandyari T; Farassati F
PLoS One; 2009 Aug; 4(8):e6514. PubMed ID: 19652721
[TBL] [Abstract][Full Text] [Related]
19. Molecular analysis of human cancer cells infected by an oncolytic HSV-1 reveals multiple upregulated cellular genes and a role for SOCS1 in virus replication.
Mahller YY; Sakthivel B; Baird WH; Aronow BJ; Hsu YH; Cripe TP; Mehrian-Shai R
Cancer Gene Ther; 2008 Nov; 15(11):733-41. PubMed ID: 18551144
[TBL] [Abstract][Full Text] [Related]
20. The role of neurofibromin in N-Ras mediated AP-1 regulation in malignant peripheral nerve sheath tumors.
Kraniak JM; Sun D; Mattingly RR; Reiners JJ; Tainsky MA
Mol Cell Biochem; 2010 Nov; 344(1-2):267-76. PubMed ID: 20680410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
